New orientations of research in Chinese medicines
Keywords:
Radix puerariae, osteoporosis, Cordyceps sinensis, ligustilide, colchicine, osteoporosi, colchicinaAbstract
SummaryPearL Materia Medica Development (Shenzhen) Ltd. and the State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Shenzhen, China form a research facility that has been recognized by the Ministry of Science and Technology of the People’s Republic of China as being unique. Besides chirotechnology, research & development are focusing on modernization of Chinese medicine, functional foods, and natural substances. These developments fall in line with a general trend well documented in eCAM (1-5). Recently developed products are cardiovascular drugs vs. ischemia, a compound formula from triptolide vs. rheumatoid arthritis, diverse plant extracts vs. osteoporosis, Z-ligustilide, as well as anti-cancer and anti-oxidant compounds from Traditional Chinese Medicine.
Nuovi orientamenti della ricerca della Medicina Cinese
Riassunto
PearL Materia Medica Development (Shenzhen) Ltd. e lo State Key Laboratory di Medicina Cinese e Farmacologia Molecolare a Shenzhen, Cina, formano una struttura di ricerca che è stata riconosciuta dal Ministero della Scienza e della Tecnologia della Repubblica Popolare Cinese come unica nel suo genere. Oltre alla chirotecnologia, la ricerca e lo sviluppo si concentrano sulla modernizzazione della Medicina Cinese, sugli alimenti funzionali e sulle sostanze naturali. Questi sviluppi sono in linea con una tendenza generale ben documentata in eCAM (1-5). I prodotti recentemente sviluppati sono farmaci cardiovascolari contro l’ischemia, la formula di un composto derivato dal triptolide contro l’artrite reumatoide, vari estratti vegetali contro l’osteoporosi, Z-ligustilide, così come composti anti-cancro e anti-ossidanti provenienti dalla Medicina Tradizionale Cinese.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
